148 related articles for article (PubMed ID: 16052674)
21. Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101.
Lv X; Li J; Yang B
Oncol Rep; 2016 Oct; 36(4):2184-92. PubMed ID: 27498785
[TBL] [Abstract][Full Text] [Related]
22. [Mutations of tumor suppressor gene PTEN mutations in hepatocellular carcinoma and its implications in tumor proliferation and apoptosis].
Guo SP; Wang L; Wang WL; Li QL; Wang WY; Zhang J
Zhonghua Bing Li Xue Za Zhi; 2006 Aug; 35(8):467-72. PubMed ID: 17069699
[TBL] [Abstract][Full Text] [Related]
23. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma.
Huang J; Zhang YL; Teng XM; Lin Y; Zheng DL; Yang PY; Han ZG
BMC Cancer; 2007 Jul; 7():126. PubMed ID: 17626620
[TBL] [Abstract][Full Text] [Related]
25. Expression and significance of PTEN and miR-92 in hepatocellular carcinoma.
Zhao B; Zhu Y; Cui K; Gao J; Yu F; Chen L; Li S
Mol Med Rep; 2013 May; 7(5):1413-6. PubMed ID: 23546593
[TBL] [Abstract][Full Text] [Related]
26. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ
Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502
[TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis.
Gomez-Manzano C; Fueyo J; Jiang H; Glass TL; Lee HY; Hu M; Liu JL; Jasti SL; Liu TJ; Conrad CA; Yung WK
Ann Neurol; 2003 Jan; 53(1):109-17. PubMed ID: 12509854
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of STRAP promotes tumor growth and metastasis in hepatocellular carcinoma via reducing PTEN level.
Wu Q; Yu S; Chen J; Li Y; Gao Y
IUBMB Life; 2018 Feb; 70(2):120-128. PubMed ID: 29283497
[TBL] [Abstract][Full Text] [Related]
31. [Methylation detection of phosphatase and tensin homolog deleted on chromosome ten gene promoter in hepatocellular carcinoma samples by next-generation sequencing].
Jing XK; Jiang QY; Li CS; Zhang NR; Chai YT; Feng F; Li BA; Li YK
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Oct; 55(10):1220-1227. PubMed ID: 34706508
[No Abstract] [Full Text] [Related]
32. The relationship between PTEN expression and anoikis in human lung carcinoma cell lines.
Lei QY; Wang LY; Dai ZY; Zha XL
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jul; 34(4):463-8. PubMed ID: 12098769
[TBL] [Abstract][Full Text] [Related]
33. PTEN and hTERT gene expression and the correlation with human hepatocellular carcinoma.
Zhou X; Zhu H; Lu J
Pathol Res Pract; 2015 Apr; 211(4):316-9. PubMed ID: 25613699
[TBL] [Abstract][Full Text] [Related]
34. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
35. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
Zhao R; Wang N; Huang H; Ma W; Yan Q
Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
[TBL] [Abstract][Full Text] [Related]
36. Hypermethylation of the PTEN gene in ovarian cancer cell lines.
Schöndorf T; Ebert MP; Hoffmann J; Becker M; Moser N; Pur S; Göhring UJ; Weisshaar MP
Cancer Lett; 2004 Apr; 207(2):215-20. PubMed ID: 15072831
[TBL] [Abstract][Full Text] [Related]
37. Effects of mutation and expression of PTEN gene mRNA on tumorigenesis and progression of epithelial ovarian cancer.
Chen Y; Zheng H; Yang X; Sun L; Xin Y
Chin Med Sci J; 2004 Mar; 19(1):25-30. PubMed ID: 15104221
[TBL] [Abstract][Full Text] [Related]
38. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
39. Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COX II and inducible nitric oxide synthase.
Rahman MA; Kyriazanos ID; Ono T; Yamanoi A; Kohno H; Tsuchiya M; Nagasue N
Int J Cancer; 2002 Jul; 100(2):152-7. PubMed ID: 12115563
[TBL] [Abstract][Full Text] [Related]
40. [Loss and inactivation of PTEN/MMAC1/TEP1 gene in lung cancer].
Zhang L; Liu T; Liu H; Gao J; Gu C
Zhonghua Bing Li Xue Za Zhi; 2000 Apr; 29(2):85-8. PubMed ID: 11866895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
